STAT

Trump administration unveils drug strategy document after lengthy delay

Two years in the making, the Trump administration has unveiled its National Drug Control Strategy, a typically annual report outlining the government’s plan to police illegal drugs, reduce drug demand,…
President Donald Trump speaks during an East Room event at the White House.

WASHINGTON — The Trump administration on Thursday unveiled a strategic planning document two years in the making: the National Drug Control Strategy, traditionally a wide-ranging annual report that outlines the government’s approach to policing illegal drugs, reducing drug demand, and treating addiction.

Though President Trump pledged to make the opioid crisis a top priority

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
STAT1 min read
STAT+: Element Biosciences, An Illumina Rival, On Its Genomics Ambitions — And Why It Hasn’t Gone Public
Element Biosciences' modest growth comes at a time when some other players are struggling in a sequencer market dominated by Illumina.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

Related Books & Audiobooks